Novo Nordisk Annual Revenue 2024. As of december 2024 novo nordisk's ttm revenue is of hk$308.45 billion companies: Morgan stanley has initiated hims & hers health (nyse:hims) at overweight saying it sees strong annual revenue growth through 2026.
Novo nordisk annual gross profit for 2023 was $28.531b, a. Novo nordisk’s latest attempt in weight loss, a combination drug called cagrisema, matched the bar set by lilly’s currently approved medicine, zepbound, but didn’t cleanly.